Cargando…
Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
Neoantigens are tumor‐specific mutated proteins that are exempt from central tolerance and are therefore capable of efficiently eliciting effective T‐cell responses. The identification of immunogenic neoantigens in tumor‐specific mutated proteins has promising clinical implications for cancer immuno...
Autores principales: | Leng, Qibin, Tarbe, Marion, Long, Qi, Wang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085466/ https://www.ncbi.nlm.nih.gov/pubmed/32211191 http://dx.doi.org/10.1002/cti2.1111 |
Ejemplares similares
-
Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019) -
Molecular mechanism of phosphopeptide neoantigen immunogenicity
por: Patskovsky, Yury, et al.
Publicado: (2023) -
Cancer neoantigens and immunogenicity: mutation position matters
por: Capietto, Aude-Hélène, et al.
Publicado: (2020) -
Pre-existing heterologous immunity to poliovirus vaccination may mitigate severity of hand, food and mouth disease caused by EV71
por: Leng, Q, et al.
Publicado: (2011) -
3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
por: Devlin, Jason, et al.
Publicado: (2019)